By: Global Animal Health Desk
Published: October 2023
Main Facts
Rabbit Hemorrhagic Disease Virus 2 (RHDV2)—also known as Rabbit Hemorrhagic Disease Virus Serotype 2—represents one of the most significant biological threats to domestic and wild rabbit populations globally. Highly contagious, exceptionally resilient, and frequently fatal, the virus has transitioned from an exotic livestock disease to a widespread ecological and domestic emergency.
In a recent episode of Medgene’s podcast, Every Animal Has an Owner, renowned veterinary specialists Dr. Amanda Jones and Dr. Anthony Pilny provided an unflinching examination of this pathogen. Their discussion covers the clinical devastation RHDV2 wreaks on lagomorphs, the sophisticated forensic methodologies used to identify and trace outbreaks, and a sobering forecast regarding the virus’s inevitable mutations.
Key facts surrounding the current landscape of RHDV2 include:
- High Mortality Rates: RHDV2 boasts a mortality rate often exceeding 70% to 90% in infected populations, frequently killing animals before owners or handlers notice outward signs of illness.
- Environmental Persistence: The virus can survive extreme temperatures and remain viable on surfaces, feed, clothing, and footwear for months, making containment exceptionally difficult.
- Broad Host Range: Unlike older strains of RHDV that primarily targeted European rabbits (Oryctolagus cuniculus), RHDV2 affects both domestic rabbits and multiple wild hare and cottontail species.
- Diagnostic Precision: Forensic pathology and molecular diagnostics play a vital role in differentiating RHDV2 from other hemorrhagic conditions, allowing biosecurity teams to trace transmission vectors.
- Evolutionary Pressure: As the virus encounters widespread immunity, vaccination campaigns, and shifting host populations, experts warn that novel mutations are not a matter of if, but when.
Chronology of an Emerging Crisis
The history of Rabbit Hemorrhagic Disease is marked by rapid geographic expansion and continuous viral adaptation. Understanding the trajectory of RHDV2 requires examining how a localized foreign animal disease evolved into a global veterinary concern.
1. Discovery and Early Spread (2010–2015)
RHDV2 was first detected in the Iberian Peninsula (France and Portugal) around 2010. Veterinary pathologists quickly realized that this new strain differed antigenically and genetically from the classical RHDV strains that had emerged in the 1980s. Unlike its predecessor, RHDV2 demonstrated the ability to infect younger rabbits (under two months of age) and cross species barriers to infect various wild hare species. Within a few years, the virus marched across Europe, establishing endemic reservoirs in wild rabbit populations in the United Kingdom, Italy, Spain, and Germany.
2. Transoceanic Leaps and North American Arrival (2018–2020)
For years, North America remained largely insulated from RHDV2, bolstered by strict import regulations and biosecurity protocols. However, in 2018, isolated cases appeared in domestic rabbits in Ohio and Canada, successfully stamped out through rapid quarantine and depopolization.
The turning point occurred in early 2020, when a massive epizootic erupted in the southwestern United States and northern Mexico. Affecting wild jackrabbits, cottontails, and domestic rabbits alike, the outbreak tore through Arizona, California, New Mexico, Nevada, Colorado, Texas, and Utah. This event shifted RHDV2 from a localized domestic animal issue to a wildlife conservation crisis.
3. Vaccine Development and Emergency Authorizations (2020–2022)
As death tolls mounted among pet rabbits and native wildlife populations, regulatory bodies, including the USDA Center for Veterinary Biologics (CVB), scrambled to grant emergency use authorizations (EUAs) for imported and domestically produced vaccines. Veterinary practitioners across North America began mass vaccination drives, though supply chain bottlenecks and strict storage requirements posed ongoing challenges.
4. The Modern Era: Endemic Management and Genetic Surveillance (2023–Present)
Today, RHDV2 is considered endemic in large parts of North America and Europe. Veterinary medicine has shifted from eradication strategies to long-term management, focusing on biosecurity, continuous vaccination, and genomic surveillance to monitor how the virus adapts under immune pressure.
Supporting Data and Pathology
To understand why Dr. Jones and Dr. Pilny describe RHDV2 with such urgency, one must examine the clinical pathology and epidemiological data associated with the virus.
Clinical Presentation and Progression
RHDV2 is a calicivirus that primarily targets the liver, causing severe hepatic necrosis (liver cell death). Secondary systemic effects include disseminated intravascular coagulation (DIC), widespread internal hemorrhaging, and multi-organ failure.
- Incubation Period: Typically short, ranging from 1 to 5 days post-exposure.
- Acute Symptoms: Often nonexistent. Many owners report finding their rabbits dead with no prior signs of illness. When symptoms do manifest, they include lethargy, fever, respiratory distress, neurological signs (such as ataxia or spasms), and bloody discharge from the nose or eyes shortly before death.
- Post-Mortem Findings: During necropsy, pathologists frequently observe an enlarged, pale, mottled, and friable liver, alongside congestion in the lungs and hemorrhages on the heart muscle and kidneys.
Transmission Vectors
The resilience of the virus makes it notoriously difficult to control. RHDV2 spreads via:
- Direct Contact: Nose-to-nose contact between infected and susceptible rabbits.
- Fomites: Contaminated cages, food bowls, bedding, clothing, and footwear.
- Insects and Scavengers: Flies, fleas, and birds can act as mechanical vectors, carrying the virus on their bodies or in their digestive tracts over significant distances.
- Aero-solization: The virus can travel short distances through the air in respiratory secretions.
Official Responses and Veterinary Perspectives
Public health agencies, wildlife management divisions, and private practitioners have had to adapt rapidly to the RHDV2 threat. On Every Animal Has an Owner, Dr. Amanda Jones and Dr. Pilny broke down the front-line realities of managing the disease, emphasizing the intersection of clinical care and veterinary forensics.
The Role of Veterinary Forensics
Evaluating an RHDV2 outbreak goes beyond clinical observation; it requires meticulous forensic investigation. Veterinarians and state epidemiologists must trace the source of infection to prevent regional spread. This involves:
- Traceback Analysis: Interviewing owners about recent feed purchases, travel, exposure to outdoor environments, or contact with other animals.
- Sample Collection: Gathering fresh liver and spleen tissues for Reverse Transcription-Polymerase Chain Reaction (RT-PCR) testing in accredited virology laboratories.
- Environmental Sampling: Testing soil, water sources, and fomites in affected wildlife habitats or commercial breeding facilities to identify lingering viral reservoirs.
Vaccination and Prophylaxis
Official guidance from organizations like the USDA and the House Rabbit Society emphasizes vaccination as the primary defense for domestic rabbits. Unlike traditional vaccines that required complex import waivers, licensed vaccines are increasingly available through veterinary channels.
However, Dr. Jones and Dr. Pilny stress that vaccination is not a silver bullet. Immunity takes time to develop post-injection, and annual boosters are required. Furthermore, vaccines protect individual pets from severe disease and death, but they do not eliminate the risk of environmental contamination or shield susceptible wild populations that cannot be realistically vaccinated en masse.
Implications: The Inevitable Mutation Threat
Perhaps the most compelling portion of the expert discussion on Every Animal Has an Owner centers on the future. Viruses under intense evolutionary pressure—such as those facing widespread population immunity, environmental stressors, and cross-species transmission—frequently undergo genetic drift and shift.
What Lies Ahead for RHDV2?
- Antigenic Drift: As more domestic rabbits are vaccinated and wild populations develop natural immunity, RHDV2 will undergo selective pressure to mutate, potentially rendering current vaccine formulations less effective. Continuous genomic sequencing is vital to stay ahead of these shifts.
- Expanded Host Tropism: RHDV2 has already demonstrated an unsettling ability to jump between lagomorph species (from European rabbits to North American cottontails and hares). Future mutations could further optimize the virus for novel hosts, threatening endangered or vulnerable wild rabbit species globally.
- Heightened Environmental Resilience: While the virus is already remarkably stable in the environment, further adaptation could enhance its resistance to standard disinfectants, complicating biosecurity protocols in veterinary hospitals, shelters, and breeding facilities.
A Call for Global Vigilance
The insights shared by Dr. Jones and Dr. Pilny serve as both a warning and a roadmap. Mitigating the future impact of RHDV2 requires a unified front combining rigorous biosecurity at the rabbitry and household levels, continued funding for molecular research, proactive vaccine distribution, and robust international surveillance networks.
As RHDV2 continues to evolve, the veterinary community remains on high alert. Protecting both beloved house pets and fragile ecosystems hinges on our ability to anticipate the virus’s next move before it strikes.
